Article Details

Roche (RHHBY) Actemra Gets FDA Nod for Adults With COVID-19 - Zacks

Retrieved on: 2022-12-22 13:04:53

Tags for this article:

Click the tags to see associated articles and topics

Roche (RHHBY) Actemra Gets FDA Nod for Adults With COVID-19 - Zacks. View article details on HISWAI: https://www.zacks.com/stock/news/2031367/roche-(rhhby)-actemra-gets-fda-nod-for-adults-with-covid-19

Excerpt

Roche (RHHBY) obtains FDA approval for Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients.

Article found on: www.zacks.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up